1.0Kuwait News Gazettehttps://kuwaitnewsgazette.comWeb Deskhttps://kuwaitnewsgazette.com/author/webdesk/rich600338<blockquote class="wp-embedded-content" data-secret="aFGgp3xHjS"><a href="https://kuwaitnewsgazette.com/fda-limits-use-of-regeneron-lilly-covid-19-antibody-treatments/">FDA Limits Use of Regeneron, Lilly COVID-19 Antibody Treatments</a></blockquote><iframe sandbox="allow-scripts" security="restricted" src="https://kuwaitnewsgazette.com/fda-limits-use-of-regeneron-lilly-covid-19-antibody-treatments/embed/#?secret=aFGgp3xHjS" width="600" height="338" title="“FDA Limits Use of Regeneron, Lilly COVID-19 Antibody Treatments” — Kuwait News Gazette" data-secret="aFGgp3xHjS" frameborder="0" marginwidth="0" marginheight="0" scrolling="no" class="wp-embedded-content"></iframe><script> /*! This file is auto-generated */ !function(d,l){"use strict";l.querySelector&&d.addEventListener&&"undefined"!=typeof URL&&(d.wp=d.wp||{},d.wp.receiveEmbedMessage||(d.wp.receiveEmbedMessage=function(e){var t=e.data;if((t||t.secret||t.message||t.value)&&!/[^a-zA-Z0-9]/.test(t.secret)){for(var s,r,n,a=l.querySelectorAll('iframe[data-secret="'+t.secret+'"]'),o=l.querySelectorAll('blockquote[data-secret="'+t.secret+'"]'),c=new RegExp("^https?:$","i"),i=0;i<o.length;i++)o[i].style.display="none";for(i=0;i<a.length;i++)s=a[i],e.source===s.contentWindow&&(s.removeAttribute("style"),"height"===t.message?(1e3<(r=parseInt(t.value,10))?r=1e3:~~r<200&&(r=200),s.height=r):"link"===t.message&&(r=new URL(s.getAttribute("src")),n=new URL(t.value),c.test(n.protocol))&&n.host===r.host&&l.activeElement===s&&(d.top.location.href=t.value))}},d.addEventListener("message",d.wp.receiveEmbedMessage,!1),l.addEventListener("DOMContentLoaded",function(){for(var e,t,s=l.querySelectorAll("iframe.wp-embedded-content"),r=0;r<s.length;r++)(t=(e=s[r]).getAttribute("data-secret"))||(t=Math.random().toString(36).substring(2,12),e.src+="#?secret="+t,e.setAttribute("data-secret",t)),e.contentWindow.postMessage({message:"ready",secret:t},"*")},!1)))}(window,document); </script> The U.S. health regulator on Monday revised the emergency use authorizations for COVID-19 antibody treatments from Regeneron and Eli Lilly to limit their use, as the drugs are unlikely to work against the omicron variant. The Food and Drug Administration (FDA) said the treatments are currently not cleared for use in any U.S. states or ... Read more